New Ways to Target Androgens in Prostate Cancer

Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives to the traditional methods that frequently carry high side effects. Read more.

June 2012 Newsletter

The June 2012 Newsletter is available by clicking here Some of the content: Wake Up call Breakfast Dr. Uri Lindner at July 25, 2012 Scotiabank Awareness Night Two Dieticians speaks at March Scotiabank Awareness Night Dr. Singal speaks at May Scotiabank Awareness Night Meet Philip Ng PCCN Conference – Regina Words from Ken Hunter PCCN-Toronto makes donations to 3 hospitals On-going Projects for 2012 The PCCN-Toronto Board of Directors (including photo)  

Cancer on the Brain – Cancer Phobia

I got a call from a friend last year. He had prostate cancer and wanted some help thinking through what to do. He had gone to his doctors for the details about his physical condition. He was calling me for help dealing with the other condition he knew he was facing — excessive fear of this dreaded disease that sometimes does more harm than good, what some have called “cancer phobia.” Read More

Survival Better with Continuous ADT

CHICAGO—Intermittent androgen deprivation therapy (ADT) has some quality-of-life (QOL) benefits for men with metastatic prostate cancer (PCa), but overall survival times are inferior to those seen with continuous ADT, according to the findings of a 17-year study (SWOG9346) presented at the American Society for Clinical Oncology 2012 annual meeting. Read More

Focal HIFU

It is hoped the new treatment, which involves heating only the tumours with a highly focused ultrasound, will mean men can be treated without an overnight stay in hospital and avoiding the distressing side effects associated with current therapies. Read more.

Scroll to Top